Mi-thos® Transcatheter Mitral Valve Replacement Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Mi-thos® Transcatheter Mitral Valve Replacement Study — Stella

Recruiting

Back to Mitral Valve Regurgitation trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(3 sites)

China

Fuwai hospital, Beijing, Beijing Municipality

Zhongshan Hospital, Shanghai, Shanghai Municipality

Xijing hospital, Xi’an, Shanxi

Key details

Sponsor

Shanghai NewMed Medical Co., Ltd.

Enrollment target

~122 participants

Started

March 2021

Primary completion

May 2026

Age range

65 Years and older

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov